Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ...
The cell therapy maker said Thursday the raise will support an ongoing trial of its experimental treatment for the ...
For individuals recovering from neurological conditions such as stroke, traumatic brain injury (TBI), multiple sclerosis, ...
Aspen Neuroscience raises $115M Series C to advance its autologous iPSC-derived Parkinson’s therapy, scale manufacturing.
ScienceAlert on MSN
Parkinson's Link to Gut Bacteria Suggests Unexpectedly Simple Treatment
Researchers have suspected for some time that the link between our gut and brain plays a role in the onset of Parkinson's ...
A high-speed “zap-and-freeze” method is giving scientists their clearest view yet of how brain cells send messages. By ...
Exercise is the only intervention that can slow the progression of Parkinson’s. A physical therapist offers expert advice on how to get moving. Parkinson’s disease (PD) is a progressive disorder that ...
News-Medical.Net on MSN
Treating sleep apnea can lower Parkinson’s disease risk
By Dr. Sanchari Sinha Dutta, Ph.D. A massive study of more than 11 million U.S. veterans reveals that treating sleep apnea ...
GlobalData on MSN
Aspen closes $115m in Series C to advance Parkinson’s cell therapy
The funding round was jointly led by OrbiMed, Frazier Life Sciences, ARCH Venture Partners and Revelation Partners.
Many people with Parkinson’s disease experience speech and swallowing difficulties that can weaken their voice or make them difficult to understand. Thanks to a grant from the Parkinson Voice Project, ...
News-Medical.Net on MSN
Untreated restless legs syndrome may increase Parkinson's disease risk
Restless legs syndrome (RLS) is a common neurological sleep disorder characterized by an uncontrollable urge to move the legs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results